Invention Grant
- Patent Title: ALPHA2C adrenoreceptor agonists
- Patent Title (中): ALPHA2C肾上腺素受体激动剂
-
Application No.: US12722879Application Date: 2010-03-12
-
Publication No.: US07985748B2Publication Date: 2011-07-26
- Inventor: Kevin D. McCormick , Christopher W. Boyce , Neng-Yang Shih , Robert G. Aslanian , Pietro Mangiaracina , Manuel de Lera Ruiz , Younong Yu , Purakkattle Biju , Chia-Yu Huang , Bo Liang , Ruiyan Liu , Rong-Qiang Liu , Lisa Guise-Zawacki
- Applicant: Kevin D. McCormick , Christopher W. Boyce , Neng-Yang Shih , Robert G. Aslanian , Pietro Mangiaracina , Manuel de Lera Ruiz , Younong Yu , Purakkattle Biju , Chia-Yu Huang , Bo Liang , Ruiyan Liu , Rong-Qiang Liu , Lisa Guise-Zawacki
- Applicant Address: US NJ Princeton US NJ Kenilworth
- Assignee: Pharmacopeia Drug Discovery, Inc.,Scheeing Corporation
- Current Assignee: Pharmacopeia Drug Discovery, Inc.,Scheeing Corporation
- Current Assignee Address: US NJ Princeton US NJ Kenilworth
- Agent Gerard Devlin; H. Eric Fischer
- Main IPC: C07D413/06
- IPC: C07D413/06 ; A61K31/538
Abstract:
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as α2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the α2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.
Public/Granted literature
- US20100173823A1 ALPHA2C ADRENORECEPTOR AGONISTS Public/Granted day:2010-07-08
Information query
